Optimising Device Design for New-Generation Biologics

International Pharmaceutical Industry (IPI) is a peer-reviewed journal providing the pharmaceutical and biopharmaceutical industry with coverage on key scientific, technology, regulatory and business topics. The publication has a global audience of professionals involved in outsourcing management for this sector.

The increase in subcutaneous injection as a route of administration for drug delivery is the result of converging trends in the pharmaceutical and healthcare sectors. New waves of biological drugs may vastly improve treatment for many diseases, but not without adapted delivery devices for effective subcutaneous administration.

There is a need for innovative drug delivery devices that accommodate higher viscosity and higher-volume formulations, typical of new biologics and biosimilars.